首页 > 最新文献

Current Pediatric Reviews最新文献

英文 中文
Laryngeal Mask for Minimally-Invasive Surfactant Administration: A Narrative Review. 用于微创表面活性物质给药的喉罩:叙述性综述。
IF 1.3 Q3 PEDIATRICS Pub Date : 2024-09-03 DOI: 10.2174/0115733963328784240820062714
Giuseppe De Bernardo, Valeria Crisci, Fabio Centanni, Maurizio Giordano, Serafina Perrone, Giuseppe Buonocore, Claudia Mandato

The cornerstone of treatment for respiratory distress syndrome in preterm infants is surfactant administration, traditionally performed through an invasive procedure involving tracheal intubation and mechanical ventilation. Consequently, there has been a growing interest in exploring less invasive methods of surfactant delivery to mitigate the associated risks. Currently, several techniques are under evaluation, including intratracheal instillation using a thin catheter, aerosolized or nebulized administration, and guided administration by supraglottic airway devices. One such method is surfactant administration through laryngeal or supraglottic airway, which involves placing a laryngeal mask without the need for laryngoscopy and administering surfactant through the device. The simplicity of laryngeal mask insertion could potentially streamline the surfactant delivery process, eliminating the necessity for advanced skills. This narrative review aimed to assess the current evidence in the literature regarding the benefits and risks associated with surfactant administration through a laryngeal supraglottic airway.

早产儿呼吸窘迫综合征的治疗基石是表面活性物质的给药,传统上是通过气管插管和机械通气等侵入性程序进行的。因此,人们越来越有兴趣探索创伤较小的表面活性物质给药方法,以降低相关风险。目前,正在对几种技术进行评估,包括使用细导管进行气管内灌注、气溶胶或雾化给药,以及通过声门上气道装置引导给药。其中一种方法是通过喉或声门上气道给药表面活性物质,这包括放置喉罩而无需喉镜检查,并通过该装置给药表面活性物质。喉罩插入的简便性有可能简化表面活性物质的输送过程,从而无需高级技能。本叙述性综述旨在评估目前文献中有关通过喉罩声门上气道给药表面活性物质的益处和风险的证据。
{"title":"Laryngeal Mask for Minimally-Invasive Surfactant Administration: A Narrative Review.","authors":"Giuseppe De Bernardo, Valeria Crisci, Fabio Centanni, Maurizio Giordano, Serafina Perrone, Giuseppe Buonocore, Claudia Mandato","doi":"10.2174/0115733963328784240820062714","DOIUrl":"https://doi.org/10.2174/0115733963328784240820062714","url":null,"abstract":"<p><p>The cornerstone of treatment for respiratory distress syndrome in preterm infants is surfactant administration, traditionally performed through an invasive procedure involving tracheal intubation and mechanical ventilation. Consequently, there has been a growing interest in exploring less invasive methods of surfactant delivery to mitigate the associated risks. Currently, several techniques are under evaluation, including intratracheal instillation using a thin catheter, aerosolized or nebulized administration, and guided administration by supraglottic airway devices. One such method is surfactant administration through laryngeal or supraglottic airway, which involves placing a laryngeal mask without the need for laryngoscopy and administering surfactant through the device. The simplicity of laryngeal mask insertion could potentially streamline the surfactant delivery process, eliminating the necessity for advanced skills. This narrative review aimed to assess the current evidence in the literature regarding the benefits and risks associated with surfactant administration through a laryngeal supraglottic airway.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Quantitative Review of Un-licensed and Off-label Medicines Use in Children Aged 0-2 Years in the Private Sector in South Africa: Extent, Challenges, and Implications. 对南非私营部门 0-2 岁儿童无证和标示外用药的定量研究:程度、挑战和影响》。
IF 1.3 Q3 PEDIATRICS Pub Date : 2024-09-03 DOI: 10.2174/0115733963303583240820043749
Hlayiseka Mathevula, Moliehi Matlala, Natalie Schellack, Samuel Orubu

Background: The global lack of suitable formulations for children leads to off-label and unlicensed medicine use, posing significant risks of adverse effects. Understanding this usage on a national level can help guide interventions for better formulations. This study aimed to measure the prevalence of off-label and unlicensed medicines among children in South Africa's private sector.

Methods: The study used a point prevalence methodology to review medicine use in children aged 0-2 years enrolled in a selected pharmaceutical benefit management company in South Africa from January to June 2022. A sample size of 1055 prescriptions was calculated using a 90% confidence interval, 50% prevalence rate, and 5% error margin. A systematic random sampling approach selected every seventh entry from 91,973 total entries, resulting in a final sample size of 13,139. Data included patient age, number and characteristics of medicines, quantity, and indications. Descriptive statistics analysed and reported the prevalence of unlicensed and off-label medicine use.

Results: Among the 13,139 prescribed medicines, 40% (5,246) were off-label or unlicensed, and 60% (7,893) were on-label. Of the off-label/unlicensed medicines, 16.85% (2,214) were unlicensed, and 23.08% (3,032) were off-label. Methylprednisolone was the top off-label medicine, probiotics were the top unlicensed, and the ICD10 code Z76.9 was the top diagnosis.

Conclusion: The study found that 40% of children aged 0-2 years were prescribed unlicensed or off-label medicines in South Africa's private healthcare sector between January and June 2022. This suggests a widespread practice of off-label or unlicensed prescriptions in paediatric treatment in the South African private sector.

背景:全球范围内缺乏适合儿童的制剂,导致标签外和无证用药,带来巨大的不良反应风险。在全国范围内了解这种用药情况有助于指导采取干预措施,以获得更好的配方。本研究旨在衡量南非私营企业中儿童使用标签外和无证药品的普遍程度:本研究采用点流行方法,对 2022 年 1 月至 6 月期间在南非一家选定的药品福利管理公司注册的 0-2 岁儿童的用药情况进行了调查。按照 90% 的置信区间、50% 的流行率和 5% 的误差率计算出 1055 份处方的样本量。系统随机抽样方法从 91,973 个条目中每隔 7 个条目抽取一个样本,最终样本量为 13,139 个。数据包括患者年龄、药品数量和特点、数量和适应症。描述性统计分析并报告了无证用药和标签外用药的发生率:在 13,139 种处方药中,40%(5,246 种)属于标签外或无证用药,60%(7,893 种)属于标签内用药。在标签外/无证药品中,16.85%(2214 种)为无证药品,23.08%(3032 种)为标签外药品。甲泼尼龙是标签外用药的首位,益生菌是无证用药的首位,ICD10代码Z76.9是诊断的首位:研究发现,在 2022 年 1 月至 6 月期间,南非私营医疗机构为 40% 的 0-2 岁儿童开具了无证或标签外药品处方。这表明在南非私立医疗机构的儿科治疗中,无标签或无证处方的情况非常普遍。
{"title":"A Quantitative Review of Un-licensed and Off-label Medicines Use in Children Aged 0-2 Years in the Private Sector in South Africa: Extent, Challenges, and Implications.","authors":"Hlayiseka Mathevula, Moliehi Matlala, Natalie Schellack, Samuel Orubu","doi":"10.2174/0115733963303583240820043749","DOIUrl":"https://doi.org/10.2174/0115733963303583240820043749","url":null,"abstract":"<p><strong>Background: </strong>The global lack of suitable formulations for children leads to off-label and unlicensed medicine use, posing significant risks of adverse effects. Understanding this usage on a national level can help guide interventions for better formulations. This study aimed to measure the prevalence of off-label and unlicensed medicines among children in South Africa's private sector.</p><p><strong>Methods: </strong>The study used a point prevalence methodology to review medicine use in children aged 0-2 years enrolled in a selected pharmaceutical benefit management company in South Africa from January to June 2022. A sample size of 1055 prescriptions was calculated using a 90% confidence interval, 50% prevalence rate, and 5% error margin. A systematic random sampling approach selected every seventh entry from 91,973 total entries, resulting in a final sample size of 13,139. Data included patient age, number and characteristics of medicines, quantity, and indications. Descriptive statistics analysed and reported the prevalence of unlicensed and off-label medicine use.</p><p><strong>Results: </strong>Among the 13,139 prescribed medicines, 40% (5,246) were off-label or unlicensed, and 60% (7,893) were on-label. Of the off-label/unlicensed medicines, 16.85% (2,214) were unlicensed, and 23.08% (3,032) were off-label. Methylprednisolone was the top off-label medicine, probiotics were the top unlicensed, and the ICD10 code Z76.9 was the top diagnosis.</p><p><strong>Conclusion: </strong>The study found that 40% of children aged 0-2 years were prescribed unlicensed or off-label medicines in South Africa's private healthcare sector between January and June 2022. This suggests a widespread practice of off-label or unlicensed prescriptions in paediatric treatment in the South African private sector.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strategies for Pain Management after Extraction of Primary Teeth: A Systematic Review of Randomized Clinical Trials. 拔除基牙后的疼痛控制策略:随机临床试验的系统回顾。
IF 1.3 Q3 PEDIATRICS Pub Date : 2024-08-13 DOI: 10.2174/0115733963292710240725051920
Janina Rodrigues, Luiz Felipe Palma, Gabriela Seabra da Silva, Lucas Santiago França, Lívia Araújo Alves, Daniela Prócida Raggio, Tamara Kerber Tedesco

Background: In dental extractions, particularly when local anesthesia is used, it usually offers analgesic relief for a few hours. However, pain can become a notable concern in the immediate postoperative period due to the trauma experienced by both soft and hard oral tissues.

Objectives: This systematic review aimed to evaluate the most effective strategies for managing postoperative pain in primary tooth extractions.

Methods: Two examiners conducted a search across five electronic databases: MEDLINE (via PubMed), Embase, Scopus, Web of Science, CENTRAL, and OpenGray. Studies were included if they met the following criteria after reviewing their titles and abstracts: they involved children and evaluated pain management following primary tooth extraction. Subsequently, articles that described extractions performed under any form of sedation, were not conducted under local anesthesia, in an outpatient setting, and in children aged 0 to 12 years, or were not randomized controlled trials, were excluded.

Results: The search yielded 374 relevant articles, of which 9 were included. Among these, 5 utilized preoperative medications as a pain management strategy, one evaluated low-level laser therapy (LLLT) postoperatively, one assessed calendula drops postoperatively, and another explored virtual reality during the procedure and arnica in solution both pre and postoperatively.

Conclusion: Among all the strategies evaluated, the strategy involving analgesics administered 30 minutes before tooth extractions was supported by better-designed studies. However, there is a high risk of bias.

背景:在牙科拔牙手术中,尤其是使用局部麻醉时,通常可在数小时内缓解疼痛。然而,由于口腔软组织和硬组织受到的创伤,疼痛可能会在术后立即成为一个值得关注的问题:本系统综述旨在评估处理基牙拔除术后疼痛的最有效策略:方法: 两名审查员对五个电子数据库进行了检索:方法: 两名审查员在五个电子数据库中进行了检索:MEDLINE(通过 PubMed)、Embase、Scopus、Web of Science、CENTRAL 和 OpenGray。在审阅了研究的标题和摘要后,符合以下标准的研究均被纳入:涉及儿童并评估了拔除原牙后的疼痛管理。随后,排除了描述在任何形式的镇静剂下进行拔牙、未在局部麻醉下进行拔牙、在门诊环境下进行拔牙、拔牙对象为 0 至 12 岁儿童或非随机对照试验的文章:结果:搜索结果显示有 374 篇相关文章,其中 9 篇被纳入。其中,5 篇文章采用术前用药作为疼痛管理策略,1 篇文章评估了术后低强度激光疗法(LLLT),1 篇文章评估了术后金盏花滴剂,另一篇文章探讨了手术过程中的虚拟现实技术以及术前和术后的山金车溶液:结论:在所有评估策略中,拔牙前 30 分钟使用镇痛剂的策略得到了设计较好的研究的支持。然而,存在偏倚的风险很高。
{"title":"Strategies for Pain Management after Extraction of Primary Teeth: A Systematic Review of Randomized Clinical Trials.","authors":"Janina Rodrigues, Luiz Felipe Palma, Gabriela Seabra da Silva, Lucas Santiago França, Lívia Araújo Alves, Daniela Prócida Raggio, Tamara Kerber Tedesco","doi":"10.2174/0115733963292710240725051920","DOIUrl":"https://doi.org/10.2174/0115733963292710240725051920","url":null,"abstract":"<p><strong>Background: </strong>In dental extractions, particularly when local anesthesia is used, it usually offers analgesic relief for a few hours. However, pain can become a notable concern in the immediate postoperative period due to the trauma experienced by both soft and hard oral tissues.</p><p><strong>Objectives: </strong>This systematic review aimed to evaluate the most effective strategies for managing postoperative pain in primary tooth extractions.</p><p><strong>Methods: </strong>Two examiners conducted a search across five electronic databases: MEDLINE (via PubMed), Embase, Scopus, Web of Science, CENTRAL, and OpenGray. Studies were included if they met the following criteria after reviewing their titles and abstracts: they involved children and evaluated pain management following primary tooth extraction. Subsequently, articles that described extractions performed under any form of sedation, were not conducted under local anesthesia, in an outpatient setting, and in children aged 0 to 12 years, or were not randomized controlled trials, were excluded.</p><p><strong>Results: </strong>The search yielded 374 relevant articles, of which 9 were included. Among these, 5 utilized preoperative medications as a pain management strategy, one evaluated low-level laser therapy (LLLT) postoperatively, one assessed calendula drops postoperatively, and another explored virtual reality during the procedure and arnica in solution both pre and postoperatively.</p><p><strong>Conclusion: </strong>Among all the strategies evaluated, the strategy involving analgesics administered 30 minutes before tooth extractions was supported by better-designed studies. However, there is a high risk of bias.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141981975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Picture, Diagnosis, Management of NEC, and Effects of Probiotics on its Prevention: A Narrative Review. NEC 的临床表现、诊断、处理和益生菌的预防效果:叙述性综述。
IF 1.3 Q3 PEDIATRICS Pub Date : 2024-08-08 DOI: 10.2174/0115733963317134240801113609
Giuseppe De Bernardo, ZIello Carla, Parisi Grazia, Vecchione Carolina, Fattorusso Valentina, Spadarella Simona, Giordano Maurizio, Buonocore Giuseppe, Perrone Serafina

Preterm newborns represent a population at risk of developing intestinal dysbiosis as well as being predisposed to sepsis and Necrotizing Enterocolitis. Necrotizing Enterocolitis is a condition burdened by many complications and mortality due to an alteration of the intestinal barrier, an immaturity of the immune system, and intestinal dysbiosis. Low gestational age at birth, low birth weight, and early use of antibiotics are other predisposing factors. Instead, breast milk and probiotics are protective factors in providing intestinal homeostasis and microbiome regulation. In this mini-review, we analysed the protective role of probiotics in the onset of Necrotizing Enterocolitis in preterm populations.

早产儿是肠道菌群失调的高危人群,也是败血症和坏死性小肠结肠炎的易感人群。坏死性小肠结肠炎是一种因肠道屏障改变、免疫系统不成熟和肠道菌群失调而引起的并发症多、死亡率高的疾病。低胎龄儿、低出生体重和过早使用抗生素也是易患此病的因素。相反,母乳和益生菌是提供肠道平衡和微生物组调节的保护因素。在这篇微型综述中,我们分析了益生菌对早产儿坏死性小肠结肠炎发病的保护作用。
{"title":"Clinical Picture, Diagnosis, Management of NEC, and Effects of Probiotics on its Prevention: A Narrative Review.","authors":"Giuseppe De Bernardo, ZIello Carla, Parisi Grazia, Vecchione Carolina, Fattorusso Valentina, Spadarella Simona, Giordano Maurizio, Buonocore Giuseppe, Perrone Serafina","doi":"10.2174/0115733963317134240801113609","DOIUrl":"https://doi.org/10.2174/0115733963317134240801113609","url":null,"abstract":"<p><p>Preterm newborns represent a population at risk of developing intestinal dysbiosis as well as being predisposed to sepsis and Necrotizing Enterocolitis. Necrotizing Enterocolitis is a condition burdened by many complications and mortality due to an alteration of the intestinal barrier, an immaturity of the immune system, and intestinal dysbiosis. Low gestational age at birth, low birth weight, and early use of antibiotics are other predisposing factors. Instead, breast milk and probiotics are protective factors in providing intestinal homeostasis and microbiome regulation. In this mini-review, we analysed the protective role of probiotics in the onset of Necrotizing Enterocolitis in preterm populations.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141916355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Management of Familial Hypercholesterolemia in Children. 儿童家族性高胆固醇血症的临床治疗。
IF 1.3 Q3 PEDIATRICS Pub Date : 2024-07-30 DOI: 10.2174/0115733963283106240712073530
Kurt Widhalm, Karin Fallmann

Familial Hypercholesterolemia (FH) is one of the best-characterized inborn errors of metabolism, with an estimated prevalence of 1:250 in the general population. Only approximately 10% of the affected subjects are diagnosed and, therefore, under medical care, including drug therapy or, in severe cases, apheresis. Screening at the age of 6-10 years would be useful and cost-effective. There is enough evidence that children and adolescents with FH should be treated in order to reduce elevated Total cholesterol and LDL-c levels and, therefore, avoid the risk of early cardiovascular diseases. As FH was described more than 130 years ago, it is surprising that the knowledge of that very important metabolic disorder is insufficient. The present report describes clinical and pathophysiological characteristics and nutritional and medical therapies in children with familial hypercholesterolemia.

家族性高胆固醇血症(FH)是特征最明显的先天性代谢异常之一,在普通人群中的发病率估计为 1:250。只有约 10%的患者被确诊,并因此接受药物治疗等医疗护理,严重者还需接受血液透析治疗。在 6-10 岁时进行筛查既有用又经济。有足够的证据表明,患有 FH 的儿童和青少年应接受治疗,以降低升高的总胆固醇和低密度脂蛋白胆固醇水平,从而避免早期心血管疾病的风险。由于 FH 早在 130 多年前就已被描述,因此人们对这种非常重要的代谢性疾病的认识不足令人惊讶。本报告介绍了家族性高胆固醇血症儿童的临床和病理生理学特征以及营养和药物疗法。
{"title":"Clinical Management of Familial Hypercholesterolemia in Children.","authors":"Kurt Widhalm, Karin Fallmann","doi":"10.2174/0115733963283106240712073530","DOIUrl":"https://doi.org/10.2174/0115733963283106240712073530","url":null,"abstract":"<p><p>Familial Hypercholesterolemia (FH) is one of the best-characterized inborn errors of metabolism, with an estimated prevalence of 1:250 in the general population. Only approximately 10% of the affected subjects are diagnosed and, therefore, under medical care, including drug therapy or, in severe cases, apheresis. Screening at the age of 6-10 years would be useful and cost-effective. There is enough evidence that children and adolescents with FH should be treated in order to reduce elevated Total cholesterol and LDL-c levels and, therefore, avoid the risk of early cardiovascular diseases. As FH was described more than 130 years ago, it is surprising that the knowledge of that very important metabolic disorder is insufficient. The present report describes clinical and pathophysiological characteristics and nutritional and medical therapies in children with familial hypercholesterolemia.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141855123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Evaluation of the Impact of Antibiotic De-escalation among Paediatric Patients Admitted to Tertiary Care Hospital in Ajman, UAE: A Cross-Sectional Retrospective Observational Study. 阿联酋阿治曼三级医院收治的儿科患者中抗生素减量的影响评估:一项横断面回顾性观察研究。
IF 1.3 Q3 PEDIATRICS Pub Date : 2024-07-29 DOI: 10.2174/0115733963283670240401075342
Nour Elshaeir, Syed Wasif Gillani

Background: Antibiotic de-escalation therapy plays a vital role in reducing the risk of bacterial resistance across the globe. This study elucidates the significance, determinants, and outcomes pertaining to Antibiotic De-escalation (ADE). The ADE is acknowledged as a crucial component within Antimicrobial Stewardship Programs (ASPs). The proliferation of antimicrobial-resistant bacteria arises as an anticipated outcome of the extensive utilization of antibiotics, heightening researchers' apprehensions regarding this global challenge.

Objective: The primary objective of the study was to evaluate the usage of antibiotics in terms of clinical outcomes (re-admission within 30 days and therapy outcomes upon discharge), adverse events, duration of de-escalation, and duration of hospitalizations among pediatric patients admitted to a tertiary care hospital due to various infectious diseases.

Methodology: A retrospective study was conducted during a four-month period, from January 2022 to April 2023, at a tertiary care facility in Ajman, United Arab Emirates. Participants included in this study were based on specific inclusion and exclusion criteria.

Results: A total of 200 pediatric records were screened. The majority of participants, accounting for 66.0%, were female, and 54.0% were classified as Arabs in terms of race. The mean age was 7.5 years (± 2.8). The most prevalent symptoms reported were fever (98%), cough (75%), and sore throat (73%). Male participants were more inclined to present with bacterial infections (88.2%) compared to viral infections (3.8%), bacterial and viral co-illnesses (2.5%), or parasitic infections (1.3%) at the time of admission. Regarding clinical outcomes, 27% of patients were readmitted with the same infection type, while 52% did not experience readmission. The analysis also included information on the number of patients within each antibiotic therapy duration category, alongside the mean duration of antibiotic de-escalation in hours with standard deviation (± SD). The statistical significance of these associations was assessed using P-values, revealing a significant relationship (P < 0.0001) between the duration of antibiotic therapy and the time required for antibiotic de-escalation.

Conclusion: The study's analysis revealed that individuals readmitted to the hospital, irrespective of whether they presented with the same or a different infection type, exhibited prolonged durations of antibiotic de-escalation. This observation underscores the potential influence of the patient's clinical trajectory and the necessity for adjunctive therapeutic interventions on the duration of antibiotic de-escalation.

背景:抗生素降级疗法在降低全球细菌耐药性风险方面发挥着至关重要的作用。本研究阐明了抗生素降级(ADE)的意义、决定因素和结果。ADE 被认为是抗菌药物管理计划 (ASP) 的重要组成部分。抗生素耐药菌的扩散是广泛使用抗生素的预期结果,这加剧了研究人员对这一全球性挑战的担忧:本研究的主要目的是评估抗生素的使用情况,包括临床结果(30 天内再次入院和出院后的治疗结果)、不良事件、降级持续时间以及因各种感染性疾病入住三级医院的儿科患者的住院时间:在 2022 年 1 月至 2023 年 4 月的四个月期间,在阿拉伯联合酋长国阿治曼的一家三级医疗机构开展了一项回顾性研究。本研究根据特定的纳入和排除标准纳入参与者:共筛选出 200 份儿科病历。大部分参与者(66.0%)为女性,54.0%为阿拉伯人。平均年龄为 7.5 岁(± 2.8)。最常见的症状是发烧(98%)、咳嗽(75%)和喉咙痛(73%)。与病毒感染(3.8%)、细菌和病毒并发症(2.5%)或寄生虫感染(1.3%)相比,男性患者在入院时更倾向于细菌感染(88.2%)。在临床结果方面,27%的患者因感染类型相同而再次入院,52%的患者没有再次入院。分析还包括每个抗生素治疗持续时间类别中的患者人数,以及抗生素降级的平均持续时间(小时)和标准偏差(± SD)。使用 P 值评估了这些关联的统计学意义,结果显示抗生素治疗持续时间与抗生素降级所需时间之间存在显著关系(P < 0.0001):研究分析表明,再次入院的患者,无论感染类型相同还是不同,抗生素疗程都会延长。这一观察结果强调了患者的临床轨迹和辅助治疗干预的必要性对抗生素降级持续时间的潜在影响。
{"title":"The Evaluation of the Impact of Antibiotic De-escalation among Paediatric Patients Admitted to Tertiary Care Hospital in Ajman, UAE: A Cross-Sectional Retrospective Observational Study.","authors":"Nour Elshaeir, Syed Wasif Gillani","doi":"10.2174/0115733963283670240401075342","DOIUrl":"https://doi.org/10.2174/0115733963283670240401075342","url":null,"abstract":"<p><strong>Background: </strong>Antibiotic de-escalation therapy plays a vital role in reducing the risk of bacterial resistance across the globe. This study elucidates the significance, determinants, and outcomes pertaining to Antibiotic De-escalation (ADE). The ADE is acknowledged as a crucial component within Antimicrobial Stewardship Programs (ASPs). The proliferation of antimicrobial-resistant bacteria arises as an anticipated outcome of the extensive utilization of antibiotics, heightening researchers' apprehensions regarding this global challenge.</p><p><strong>Objective: </strong>The primary objective of the study was to evaluate the usage of antibiotics in terms of clinical outcomes (re-admission within 30 days and therapy outcomes upon discharge), adverse events, duration of de-escalation, and duration of hospitalizations among pediatric patients admitted to a tertiary care hospital due to various infectious diseases.</p><p><strong>Methodology: </strong>A retrospective study was conducted during a four-month period, from January 2022 to April 2023, at a tertiary care facility in Ajman, United Arab Emirates. Participants included in this study were based on specific inclusion and exclusion criteria.</p><p><strong>Results: </strong>A total of 200 pediatric records were screened. The majority of participants, accounting for 66.0%, were female, and 54.0% were classified as Arabs in terms of race. The mean age was 7.5 years (± 2.8). The most prevalent symptoms reported were fever (98%), cough (75%), and sore throat (73%). Male participants were more inclined to present with bacterial infections (88.2%) compared to viral infections (3.8%), bacterial and viral co-illnesses (2.5%), or parasitic infections (1.3%) at the time of admission. Regarding clinical outcomes, 27% of patients were readmitted with the same infection type, while 52% did not experience readmission. The analysis also included information on the number of patients within each antibiotic therapy duration category, alongside the mean duration of antibiotic de-escalation in hours with standard deviation (± SD). The statistical significance of these associations was assessed using P-values, revealing a significant relationship (P < 0.0001) between the duration of antibiotic therapy and the time required for antibiotic de-escalation.</p><p><strong>Conclusion: </strong>The study's analysis revealed that individuals readmitted to the hospital, irrespective of whether they presented with the same or a different infection type, exhibited prolonged durations of antibiotic de-escalation. This observation underscores the potential influence of the patient's clinical trajectory and the necessity for adjunctive therapeutic interventions on the duration of antibiotic de-escalation.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141792101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Respiratory Tract Infections in Pediatric Populations of Slum Areas: Navigating Challenges and Dynamics of Immune Responses. 贫民区儿童急性呼吸道感染:应对免疫反应的挑战和动态变化。
IF 1.3 Q3 PEDIATRICS Pub Date : 2024-07-25 DOI: 10.2174/0115733963309043240703115735
Gayathri Gunasekaran, Dinesh Kumar Thirugnanam, Ashwath Balasubramaniam, N Nalini Jayanthi, K V Leela

The study presents a thorough examination of immune responses in pediatric populations within slum areas, specifically addressing respiratory infections. It explores the impact of slum conditions on respiratory health, detailing the epidemiology of infections, including common pathogens and environmental factors. The review delves into the etiology, clinical manifestations, and challenges associated with viral respiratory infections, co-infections, and complications in slum environments. The discussion extends to immune responses in pediatric respiratory infections, emphasizing unique challenges in diagnosis and treatment within slum areas. Prevention and intervention strategies are highlighted, encompassing vaccination programs, health education, and improving living conditions. It underscores the importance of targeted interventions, accounting for socio-economic factors, community-based strategies, and culturally sensitive approaches. It proposes the exploration of novel approaches and the development of vaccines tailored to prevalent respiratory pathogens in slum settings. Furthermore, the feasibility and impact of routine immunization programs, emphasizing accessibility, acceptance, and long-term sustainability are explored. It advocates strengthening primary healthcare systems, investing in healthcare workforce training, and improving diagnostic facilities. The potential of digital health technologies in enhancing surveillance, early detection, and the development of mobile applications or telemedicine platforms is discussed. In conclusion, the study emphasizes the multifaceted challenges faced by children in slum areas regarding respiratory infections, necessitating informed, interdisciplinary interventions. Addressing healthcare disparities, improving living conditions, and enhancing vaccination coverage are deemed crucial for mitigating the burden of respiratory infections. This review calls for collaborative efforts among researchers, healthcare professionals, policymakers, and community stakeholders to develop sustainable solutions for enhanced respiratory health in slum-dwelling pediatric populations.

该研究全面考察了贫民窟地区儿科人群的免疫反应,特别是呼吸道感染。研究探讨了贫民窟条件对呼吸系统健康的影响,详细介绍了感染的流行病学,包括常见病原体和环境因素。综述深入探讨了病因、临床表现以及贫民窟环境中与病毒性呼吸道感染、合并感染和并发症相关的挑战。讨论延伸到小儿呼吸道感染的免疫反应,强调贫民窟地区诊断和治疗的独特挑战。重点介绍了预防和干预策略,包括疫苗接种计划、健康教育和改善生活条件。报告强调了有针对性的干预措施的重要性,考虑到了社会经济因素、基于社区的战略和文化敏感性方法。报告建议探索新方法,并针对贫民窟环境中流行的呼吸道病原体开发疫苗。此外,还探讨了常规免疫计划的可行性和影响,强调了可及性、可接受性和长期可持续性。报告提倡加强初级医疗保健系统,投资于医疗保健人员培训,改善诊断设施。研究还讨论了数字医疗技术在加强监测、早期检测以及开发移动应用或远程医疗平台方面的潜力。总之,本研究强调了贫民窟地区儿童在呼吸道感染方面面临的多方面挑战,因此有必要采取知情的跨学科干预措施。解决医疗保健差异、改善生活条件和提高疫苗接种覆盖率被认为是减轻呼吸道感染负担的关键。本综述呼吁研究人员、医疗保健专业人员、政策制定者和社区利益相关者通力合作,制定可持续的解决方案,以提高贫民窟居住的儿科人群的呼吸系统健康水平。
{"title":"Acute Respiratory Tract Infections in Pediatric Populations of Slum Areas: Navigating Challenges and Dynamics of Immune Responses.","authors":"Gayathri Gunasekaran, Dinesh Kumar Thirugnanam, Ashwath Balasubramaniam, N Nalini Jayanthi, K V Leela","doi":"10.2174/0115733963309043240703115735","DOIUrl":"https://doi.org/10.2174/0115733963309043240703115735","url":null,"abstract":"<p><p>The study presents a thorough examination of immune responses in pediatric populations within slum areas, specifically addressing respiratory infections. It explores the impact of slum conditions on respiratory health, detailing the epidemiology of infections, including common pathogens and environmental factors. The review delves into the etiology, clinical manifestations, and challenges associated with viral respiratory infections, co-infections, and complications in slum environments. The discussion extends to immune responses in pediatric respiratory infections, emphasizing unique challenges in diagnosis and treatment within slum areas. Prevention and intervention strategies are highlighted, encompassing vaccination programs, health education, and improving living conditions. It underscores the importance of targeted interventions, accounting for socio-economic factors, community-based strategies, and culturally sensitive approaches. It proposes the exploration of novel approaches and the development of vaccines tailored to prevalent respiratory pathogens in slum settings. Furthermore, the feasibility and impact of routine immunization programs, emphasizing accessibility, acceptance, and long-term sustainability are explored. It advocates strengthening primary healthcare systems, investing in healthcare workforce training, and improving diagnostic facilities. The potential of digital health technologies in enhancing surveillance, early detection, and the development of mobile applications or telemedicine platforms is discussed. In conclusion, the study emphasizes the multifaceted challenges faced by children in slum areas regarding respiratory infections, necessitating informed, interdisciplinary interventions. Addressing healthcare disparities, improving living conditions, and enhancing vaccination coverage are deemed crucial for mitigating the burden of respiratory infections. This review calls for collaborative efforts among researchers, healthcare professionals, policymakers, and community stakeholders to develop sustainable solutions for enhanced respiratory health in slum-dwelling pediatric populations.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141787540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Child Maltreatment and Psychopathology: A Brief Review on the Potential Role of the Hypothalamic-pituitary-adrenal Axis. 儿童虐待与精神病理学:下丘脑-垂体-肾上腺轴潜在作用简评》。
IF 1.3 Q3 PEDIATRICS Pub Date : 2024-07-25 DOI: 10.2174/0115733963316599240704061209
Pietro Ferrara, Ignazio Cammisa, Margherita Zona, Ivana Pacucci, Maria Teresa Grimaldi, Francesca Scaltrito, Ida Giardino, Alberto Verrotti, Massimo Pettoello-Mantovani

Child maltreatment is a widespread global issue involving any form of harm or neglect by a parent or caregiver, leading to various forms of physical or emotional damage, with approximately 150 million affected children globally. This study discusses the potential mechanism of the hypothalamic-pituitary-adrenal axis dysfunction and cortisol hormone changes in linking child maltreatment to mental health disorders. It also discusses supportive strategies to prevent mental diseases and counteract the biological embedding of these conditions, emphasizing the need for comprehensive interventions to address the long-term impact of child maltreatment on mental health. Articles were selected using established methods previously described. Key information was obtained from scientific articles published during the past 20 years, including original studies, systematic reviews, and meta-analyses. Articles search was performed using top academic search engines. While research on hypothalamic-pituitary-adrenal axis response to stress in maltreated children is ongoing and far from conclusive, its impact and implications for physiological functioning and the predisposition to psychopathology are significant. Childhood maltreatment increases the risk of psychiatric illnesses, severity of diseases, and poor treatment responses. Childhood maltreatment manifests as disruptions to hypothalamic-pituitary-adrenal axis functioning, with the extent varying based on factors, such as the age of onset, parental responsiveness, and the type and characteristics of maltreatment. The complex interplay of these factors contributes to the diversity of hypothalamic-pituitary-adrenal axis responses to stress in maltreated children, creating a spectrum of physiological functioning and vulnerability to psychopathology.

虐待儿童是一个普遍存在的全球性问题,涉及父母或看护人的任何形式的伤害或忽视,导致各种形式的身体或情感伤害,全球约有 1.5 亿儿童受到影响。本研究探讨了下丘脑-垂体-肾上腺轴功能障碍和皮质醇激素变化将儿童虐待与精神疾病联系起来的潜在机制。报告还讨论了预防精神疾病和抵消这些病症的生物嵌入性的支持性策略,强调需要采取综合干预措施来解决儿童虐待对精神健康的长期影响。文章的筛选采用了之前介绍过的既定方法。主要信息来自过去 20 年间发表的科学文章,包括原创研究、系统综述和荟萃分析。文章搜索使用顶级学术搜索引擎。尽管有关受虐待儿童的下丘脑-垂体-肾上腺轴对压力的反应的研究仍在进行中,且远未得出结论,但其对生理功能和心理病理学易感性的影响和意义是重大的。儿童时期的虐待会增加罹患精神疾病的风险、疾病的严重程度以及治疗效果不佳的情况。儿童虐待表现为下丘脑-垂体-肾上腺轴功能的紊乱,其程度因各种因素而异,如发病年龄、父母的反应能力以及虐待的类型和特征。这些因素的复杂相互作用导致受虐待儿童的下丘脑-垂体-肾上腺轴对压力的反应多种多样,从而产生了一系列生理功能和心理病理学脆弱性。
{"title":"Child Maltreatment and Psychopathology: A Brief Review on the Potential Role of the Hypothalamic-pituitary-adrenal Axis.","authors":"Pietro Ferrara, Ignazio Cammisa, Margherita Zona, Ivana Pacucci, Maria Teresa Grimaldi, Francesca Scaltrito, Ida Giardino, Alberto Verrotti, Massimo Pettoello-Mantovani","doi":"10.2174/0115733963316599240704061209","DOIUrl":"https://doi.org/10.2174/0115733963316599240704061209","url":null,"abstract":"<p><p>Child maltreatment is a widespread global issue involving any form of harm or neglect by a parent or caregiver, leading to various forms of physical or emotional damage, with approximately 150 million affected children globally. This study discusses the potential mechanism of the hypothalamic-pituitary-adrenal axis dysfunction and cortisol hormone changes in linking child maltreatment to mental health disorders. It also discusses supportive strategies to prevent mental diseases and counteract the biological embedding of these conditions, emphasizing the need for comprehensive interventions to address the long-term impact of child maltreatment on mental health. Articles were selected using established methods previously described. Key information was obtained from scientific articles published during the past 20 years, including original studies, systematic reviews, and meta-analyses. Articles search was performed using top academic search engines. While research on hypothalamic-pituitary-adrenal axis response to stress in maltreated children is ongoing and far from conclusive, its impact and implications for physiological functioning and the predisposition to psychopathology are significant. Childhood maltreatment increases the risk of psychiatric illnesses, severity of diseases, and poor treatment responses. Childhood maltreatment manifests as disruptions to hypothalamic-pituitary-adrenal axis functioning, with the extent varying based on factors, such as the age of onset, parental responsiveness, and the type and characteristics of maltreatment. The complex interplay of these factors contributes to the diversity of hypothalamic-pituitary-adrenal axis responses to stress in maltreated children, creating a spectrum of physiological functioning and vulnerability to psychopathology.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141787541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Awareness, Practice, and Views of Pediatricians, General Physicians, and Pharmacists about Prescribing Off-label Medication in Pediatric Patients in Eastern Province, Saudi Arabia. 沙特阿拉伯东部省儿科医生、全科医生和药剂师对给儿科患者开标签外药物处方的认识、做法和看法。
IF 1.3 Q3 PEDIATRICS Pub Date : 2024-06-26 DOI: 10.2174/0115733963298903240614072717
Layan Sameer Almintakh, Mariam Fahad Al Dossary, Abrar Mohmmadjamal Altesha, Rayanah Fahad Alqahtani, Samiah Mohammad Alsomali, Nuzhat Banu, Mohammad Daud Ali, Ayaz Ahmed

Background: An off-label medication involves the use of an approved drug for an unapproved indication, population, route of administration, or dosage.The physiological state of children differs from that of adults, making the adult formulation potentially dangerous to children. Off-label prescribing is quite common in children due to challenges in the development of pediatric formulations. The current study was conducted to determine the awareness, practice, and views of pediatricians, general physicians, and pharmacists about prescribing Off-label medication to pediatric patients in Eastern Province, Saudi Arabia.

Methods: A cross-sectional study based on a questionnaire was conducted among pediatricians, general physicians, and pharmacists (clinical and community) in Eastern Province, Saudi Arabia. Statistical analysis was conducted using the data exported from Google Forms (Mountain View, California, USA) and Microsoft Excel (Version 2016) and then exported into Statistical Package for Social Sciences (SPSS) version 26.0 (IBM, Inc., Armonk, NY, USA). Chi-square was deemed suitable. The level of significance was set at 0.05.

Results: Among the study participants, 53(35.09%) were pharmacists, followed by 24(15.89%) others, 22(14.565) pediatricians, 19(12.58%) other specialists, 17(11.25%) general physicians, and 16(10.59%) were clinical pharmacist. About 73(48.34%) described the definition of off-label correctly. About 114(75.49%) believed that parents and guardians must be informed about off-label medicine prescribed to their children. About 52(34.43%) had concerns about the safety of the medication, and 98(64.90%) believed they should be tested in pediatrics during clinical trials. Further, 97(64.23%) considered themselves not enough knowledgeable about off-label medications. The barriers reported by the participants were as follows: 89(58.945%) said lack of information resources, 71(47.01%) said lack of training, 56(37.08%) said lack of information on the safety of excipients used in pediatrics, 47(31.12%) said lack of formulary, 44(29.13%) said lack of guidelines, and 58(5.29%) said lack of information related to the safety of excipient concentration in pediatrics. The proportion of healthcare professionals who agreed that excipients in adult medication may be harmful to pediatrics was 103(68.21%). The drugs most often prescribed as off-label were paracetamol 54(21.68%), followed by Phenobarbital 35(14%), and Amoxicillin 33(13.25%).

Conclusion: There are a considerable number of healthcare professionals unaware of the description of off-label medication. The majority have concerns over the safety and efficacy of the off-label drugs and believe that most frequently used off-label drugs in pediatrics must be tested in pediatrics during clinical trials. In addition, excipient safety data are of considerable importance to ensure off-label drug safety in pedi

背景:标签外用药是指将已获批准的药物用于未获批准的适应症、人群、给药途径或剂量。儿童的生理状态与成人不同,因此成人制剂对儿童有潜在危险。由于儿科制剂的开发面临挑战,标签外处方在儿童中十分常见。本研究旨在了解沙特阿拉伯东部省的儿科医生、全科医生和药剂师对给儿科患者开标签外处方的认识、做法和看法:在沙特阿拉伯东部省的儿科医生、全科医生和药剂师(临床和社区)中开展了一项基于问卷的横断面研究。统计分析使用从谷歌表格(美国加利福尼亚州山景城)和 Microsoft Excel(2016 版)导出的数据,然后导入 26.0 版社会科学统计软件包(SPSS)(IBM 公司,美国纽约州阿蒙克)。智方被认为是合适的。显著性水平设定为 0.05:在研究参与者中,53 人(35.09%)是药剂师,其次是 24 人(15.89%)其他人员、22 人(14.565%)儿科医生、19 人(12.58%)其他专科医生、17 人(11.25%)全科医生和 16 人(10.59%)临床药师。约 73 人(48.34%)正确描述了标签外的定义。约 114 名(75.49%)受访者认为必须告知家长和监护人有关给儿童开具的标签外药物。约 52 人(34.43%)对药物的安全性表示担忧,98 人(64.90%)认为应在儿科进行临床试验。此外,97 人(64.23%)认为自己对标签外药物的了解不够。参与者遇到的障碍如下:89(58.945%)人认为缺乏信息资源,71(47.01%)人认为缺乏培训,56(37.08%)人认为缺乏有关儿科辅料安全性的信息,47(31.12%)人认为缺乏处方集,44(29.13%)人认为缺乏指南,58(5.29%)人认为缺乏有关儿科辅料浓度安全性的信息。同意成人药物中的辅料可能对儿科有害的医护人员比例为 103(68.21%)。最常作为标签外处方的药物是扑热息痛 54(21.68%),其次是苯巴比妥 35(14%)和阿莫西林 33(13.25%):结论:有相当多的医护人员不了解标签外用药的描述。结论:相当多的医护人员不了解标示外药物的描述,大多数人对标示外药物的安全性和疗效表示担忧,认为儿科常用的标示外药物必须在儿科进行临床试验。此外,辅料的安全性数据对于确保儿科标示外用药的安全性也相当重要。
{"title":"Awareness, Practice, and Views of Pediatricians, General Physicians, and Pharmacists about Prescribing Off-label Medication in Pediatric Patients in Eastern Province, Saudi Arabia.","authors":"Layan Sameer Almintakh, Mariam Fahad Al Dossary, Abrar Mohmmadjamal Altesha, Rayanah Fahad Alqahtani, Samiah Mohammad Alsomali, Nuzhat Banu, Mohammad Daud Ali, Ayaz Ahmed","doi":"10.2174/0115733963298903240614072717","DOIUrl":"https://doi.org/10.2174/0115733963298903240614072717","url":null,"abstract":"<p><strong>Background: </strong>An off-label medication involves the use of an approved drug for an unapproved indication, population, route of administration, or dosage.The physiological state of children differs from that of adults, making the adult formulation potentially dangerous to children. Off-label prescribing is quite common in children due to challenges in the development of pediatric formulations. The current study was conducted to determine the awareness, practice, and views of pediatricians, general physicians, and pharmacists about prescribing Off-label medication to pediatric patients in Eastern Province, Saudi Arabia.</p><p><strong>Methods: </strong>A cross-sectional study based on a questionnaire was conducted among pediatricians, general physicians, and pharmacists (clinical and community) in Eastern Province, Saudi Arabia. Statistical analysis was conducted using the data exported from Google Forms (Mountain View, California, USA) and Microsoft Excel (Version 2016) and then exported into Statistical Package for Social Sciences (SPSS) version 26.0 (IBM, Inc., Armonk, NY, USA). Chi-square was deemed suitable. The level of significance was set at 0.05.</p><p><strong>Results: </strong>Among the study participants, 53(35.09%) were pharmacists, followed by 24(15.89%) others, 22(14.565) pediatricians, 19(12.58%) other specialists, 17(11.25%) general physicians, and 16(10.59%) were clinical pharmacist. About 73(48.34%) described the definition of off-label correctly. About 114(75.49%) believed that parents and guardians must be informed about off-label medicine prescribed to their children. About 52(34.43%) had concerns about the safety of the medication, and 98(64.90%) believed they should be tested in pediatrics during clinical trials. Further, 97(64.23%) considered themselves not enough knowledgeable about off-label medications. The barriers reported by the participants were as follows: 89(58.945%) said lack of information resources, 71(47.01%) said lack of training, 56(37.08%) said lack of information on the safety of excipients used in pediatrics, 47(31.12%) said lack of formulary, 44(29.13%) said lack of guidelines, and 58(5.29%) said lack of information related to the safety of excipient concentration in pediatrics. The proportion of healthcare professionals who agreed that excipients in adult medication may be harmful to pediatrics was 103(68.21%). The drugs most often prescribed as off-label were paracetamol 54(21.68%), followed by Phenobarbital 35(14%), and Amoxicillin 33(13.25%).</p><p><strong>Conclusion: </strong>There are a considerable number of healthcare professionals unaware of the description of off-label medication. The majority have concerns over the safety and efficacy of the off-label drugs and believe that most frequently used off-label drugs in pediatrics must be tested in pediatrics during clinical trials. In addition, excipient safety data are of considerable importance to ensure off-label drug safety in pedi","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141455827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Outcomes of Hirschsprung's Disease after Definitive Surgery: A Ten-Year Experience. 确定性手术后的赫氏胃肠病早期疗效:十年经验
IF 1.3 Q1 Medicine Pub Date : 2024-06-20 DOI: 10.2174/0115733963271997240605103909
Muntadhar Muhammad Isa, Maimun Syukri, Muchlisin Za, Gunadi, Dian Adi Syahputra, T Yusriadi, Yumna Muzakkir, Siti Maghfirah

Introduction: This study aimed to examine the characteristics of Hirschsprung's Disease (HD) in patients aged<18 who underwent surgical procedure at Dr. Zainoel Abidin (RSUDZA) General Hospital, Banda Aceh, Indonesia, between January 2010 and December 2020.

Methods: This retrospective study collected and analyzed data from medical records of 18-yearold or younger children (n = 180) diagnosed with HD at RSUDZA. The surgical procedures included the Duhamel procedure, Soave procedure, the Soave Transanal Endorectal Pull-through (TEPT) procedure, and the Swenson TEPT procedure. Early outcomes of the surgery were then compared between males and females. The comparrative analysis was determined based on Chisquare analysis, where p< 0.05 was considered significant.

Results: There were 111 (61.7%) male patients and 69 (38.3%) female patients, with a mean age of 15.2 months. The Soave TEPT is the most frequently performed procedure (91.7%). Emerging clinical manifestations include constipation (176; 97.8%) and soiling (171; 95%). Preoperative barium enema and postoperative pathological examination confirmed that almost all patients (99.4%) had an aganglionic segment confined to the rectosigmoid area. The average length of operation was 69.7 ± 65 minutes and average bleeding time was 5.4 ± 34 mL. The average discharge time was 3.3 ± 73.3 days. No significant difference was found in post-surgery complications between males and females (p<0.5). The immediate complications were not associated with surgical methods (p = 0.83).

Conclusion: Our descriptive study has suggested the Soave TEPT technique as appropriate to manage HD.

导言:本研究旨在探讨年龄在 18 岁以下的赫氏胃肠病(Hirschsprung's Disease,HD)患者的特征:这项回顾性研究收集并分析了在皇家研究与发展中心(RSUDZA)确诊的18岁或18岁以下HD患儿(180人)的病历数据。手术方法包括 Duhamel 手术、Soave 手术、Soave 经肛门直肠内拉穿(TEPT)手术和 Swenson TEPT 手术。然后对男性和女性的早期手术结果进行比较。比较分析基于Chisquare分析,P< 0.05为显著:男性患者 111 人(61.7%),女性患者 69 人(38.3%),平均年龄 15.2 个月。Soave TEPT 是最常用的手术(91.7%)。新出现的临床表现包括便秘(176 例;97.8%)和便溺(171 例;95%)。术前钡剂灌肠和术后病理检查证实,几乎所有患者(99.4%)的aganglionic节段都局限于直肠乙状结肠区域。手术平均时间为 69.7 ± 65 分钟,平均出血时间为 5.4 ± 34 毫升。平均出院时间为 3.3 ± 73.3 天。男性和女性的术后并发症无明显差异(p<0.5)。即时并发症与手术方法无关(p = 0.83):我们的描述性研究表明,Soave TEPT 技术适用于治疗 HD。
{"title":"Early Outcomes of Hirschsprung's Disease after Definitive Surgery: A Ten-Year Experience.","authors":"Muntadhar Muhammad Isa, Maimun Syukri, Muchlisin Za, Gunadi, Dian Adi Syahputra, T Yusriadi, Yumna Muzakkir, Siti Maghfirah","doi":"10.2174/0115733963271997240605103909","DOIUrl":"https://doi.org/10.2174/0115733963271997240605103909","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to examine the characteristics of Hirschsprung's Disease (HD) in patients aged<18 who underwent surgical procedure at Dr. Zainoel Abidin (RSUDZA) General Hospital, Banda Aceh, Indonesia, between January 2010 and December 2020.</p><p><strong>Methods: </strong>This retrospective study collected and analyzed data from medical records of 18-yearold or younger children (n = 180) diagnosed with HD at RSUDZA. The surgical procedures included the Duhamel procedure, Soave procedure, the Soave Transanal Endorectal Pull-through (TEPT) procedure, and the Swenson TEPT procedure. Early outcomes of the surgery were then compared between males and females. The comparrative analysis was determined based on Chisquare analysis, where p&#60; 0.05 was considered significant.</p><p><strong>Results: </strong>There were 111 (61.7%) male patients and 69 (38.3%) female patients, with a mean age of 15.2 months. The Soave TEPT is the most frequently performed procedure (91.7%). Emerging clinical manifestations include constipation (176; 97.8%) and soiling (171; 95%). Preoperative barium enema and postoperative pathological examination confirmed that almost all patients (99.4%) had an aganglionic segment confined to the rectosigmoid area. The average length of operation was 69.7 ± 65 minutes and average bleeding time was 5.4 ± 34 mL. The average discharge time was 3.3 ± 73.3 days. No significant difference was found in post-surgery complications between males and females (p&#60;0.5). The immediate complications were not associated with surgical methods (p = 0.83).</p><p><strong>Conclusion: </strong>Our descriptive study has suggested the Soave TEPT technique as appropriate to manage HD.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141442299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Pediatric Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1